{
  "id": 17217757,
  "title": "Setara gets $90M to continue rare disease pipeline spun out of Jazz's Actio deal",
  "url": "https://urgent.news/2026/10/30/setara-gets-90m-to-continue-rare-disease-pipeline-spun-out-of-jazzs",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-30T10:30:35.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/setara-gets-90m-to-continue-rare-disease-pipeline-spun-out-of-jazzs-actio-deal/"
  },
  "original_language": "en",
  "account": null,
  "summary": "After shipping its precision epilepsy drug to Jazz Pharmaceuticals, Actio Biosciences has spun out the remainder of its genetics-driven pipeline into a new company called Setara Biosciences. Setara is getting a fresh $90 million to ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}